Science Explorer Interactive view Map
Institution · São Paulo · Brazil

Instituto Brasileiro de Controle do Câncer

World rank, all time
#41,957
of 42,892
Rank in Brazil
#843
of 870
Research works
154
▲ 96% vs 2013–17
Citations
1.7k
10.9 per fractional work
Top-10% rate
2.6%
record average 16.5%
Open access
58%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.31× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.77× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.00× its world share, 0 worksImmunology and Micro…Neuroscience: 0.27× its world share, 0 worksNeuroscienceComputer Science: 0.37× its world share, 1 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMathematics: 0.06× its world share, 0 worksMathematicsDentistry: 0.98× its world share, 0 worksDentistryMedicine: 4.07× its world share, 30 worksMedicineNursing: 0.44× its world share, 0 worksNursingBusiness, Management and Accounting: 0.17× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.44× its world share, 0 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.22× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.

Who are the top researchers at Instituto Brasileiro de Controle do Câncer?

Ranked on the composite score, Felipe Melo Cruz and André Lopes lead among researchers whose main affiliation is Instituto Brasileiro de Controle do Câncer.

  1. 1 Felipe Melo Cruz Brazil · #198,417 worldwide 131 citations · 21 works
  2. 2 André Lopes Brazil · #1,282,145 worldwide 3 citations · 27 works
All ranked researchers at Instituto Brasileiro de Controle do Câncer

Which keywords describe research at Instituto Brasileiro de Controle do Câncer?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Quality of Life, Radiotherapy, Complications, Clinical Trials, Breast Cancer, Breast Reconstruction and Metastasis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy6▲ 21×16 topics
  2. Quality of Life4▲ 7.9×10 topics
  3. Radiotherapy4▲ 25×9 topics
  4. Complications3▲ 18×4 topics
  5. Clinical Trials3▲ 12×8 topics
  6. Breast Cancer3▲ 33×8 topics
  7. Breast Reconstruction3▲ 123×2 topics
  8. Metastasis3▲ 21×3 topics
  9. Epidemiology2▲ 1.58×12 topics
  10. Ovarian Cancer2▲ 70×2 topics
  11. Biomarkers2▲ 8.7×3 topics
  12. Clinical Practice Guidelines2▲ 11×7 topics
  13. Immunotherapy2▲ 7.5×8 topics
  14. Prognostic Factors2▲ 12×10 topics
  15. Genomic Analysis2▲ 20×2 topics
  16. Cytoreductive Surgery2▲ 68×2 topics
  17. Mutation Analysis2▲ 58×1 topic
  18. Survival Analysis2▲ 16×5 topics
  19. Tumor Models2▲ 73×1 topic
  20. Acellular Dermal Matrix2▲ 191×1 topic
  21. Guidelines2▲ 8.2×3 topics
  22. Patient-Reported Outcome Measure2▲ 191×1 topic
  23. Prognostic Markers2▲ 36×2 topics
  24. Prophylaxis2▲ 29×2 topics
  25. Free Flap1▲ 89×1 topic
  26. Microsurgical Reconstruction1▲ 89×1 topic
  27. Neoadjuvant Therapy1▲ 15×4 topics
  28. Gene Expression1▲ 5.6×2 topics
  29. Targeted Therapy1▲ 15×4 topics
  30. Breast Tumours1▲ 65×1 topic
  31. Immunohistochemistry1▲ 41×3 topics
  32. Molecular Profiling1▲ 31×3 topics
  33. Treatment Response1▲ 65×1 topic
  34. Antimicrobial Agents1▲ 179×1 topic
  35. Cervical Cancer1▲ 27×3 topics
  36. Febrile Neutropenia1▲ 179×1 topic
  37. Metastatic Breast Cancer1▲ 48×2 topics
  38. Agile Software Development1▲ 109×1 topic
  39. Anatomy1▲ 37×2 topics
  40. Empirical Studies1▲ 109×1 topic

Which research topics does Instituto Brasileiro de Controle do Câncer publish most on?

By volume in 2022–2025: Ovarian cancer diagnosis and treatment, Breast Implant and Reconstruction, Reconstructive Surgery and Microvascular Techniques and Breast Cancer Treatment Studies.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
  2. 2 Breast Implant and Reconstruction Surgery 2 works
  3. 3 Reconstructive Surgery and Microvascular Techniques Surgery 1 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 1 works
  5. 5 Neutropenia and Cancer Infections Oncology 1 works
  6. 6 Software Engineering Techniques and Practices Information Systems 1 works
  7. 7 Education and Digital Technologies Sociology and Political Science 1 works
  8. 8 Cancer Treatment and Pharmacology Oncology 1 works
  9. 9 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 1 works
  10. 10 Reconstructive Facial Surgery Techniques Surgery 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.3%not open41.7%

World: 28% of research is openly available.

with international co-authors13.5%domestic only86.5%

World: 19% is written across borders.

How has Instituto Brasileiro de Controle do Câncer's research output changed?

Output in 2018–2022 was 96% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in São Paulo

All research institutions in São Paulo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.